<DOC>
	<DOCNO>NCT01301079</DOCNO>
	<brief_summary>The aim study determine addition ketamine reduce remifentanil-induced hyperalgesia , improve analgesic effect , inhibits IL ( interleukin ) -6 IL-8 ( inflammatory cytokine ) , stimulate IL-10 ( anti-inflammatory cytokine ) .</brief_summary>
	<brief_title>Evaluation Effect Ketamine Remifentanil-induced Hyperalgesia</brief_title>
	<detailed_description>Opioids effective pain relief , might lower pain threshold , make patient sensitive pain stimulus , condition know hyperalgesia [ Angst ; Clarck , 2006 ] . Opioid-induced hyperalgesia ( OIH ) usually define reduction nociceptive threshold peripheral field sensitize fiber [ Koppert et al. , 2003 ] , associate increase pain high demand postoperative analgesia [ Guignard et al. , 2000 ] . This phenomenon adversely impact pain control , suggest occur peri-operative context , especially associate use remifentanil , short-acting opioid [ Guignard et al. , 2000 ] . Several mechanism propose explain hyperalgesia phenomenon , important seem activation N-methyl-D-aspartate ( NMDA ) receptor [ Célèrier et al. , 2000 ] . Ketamine NMDA receptor antagonist show reduce postoperative pain need postoperative anesthetic analgesic . Therefore , propose ketamine could prevent hyperalgesia , result effective long-lasting postsurgical analgesia [ Célèrier et al . 2000 ] . The result study low dose ketamine prevention remifentanil-induced hyperalgesia controversial . Joly et al . [ 2005 ] demonstrate reduction consumption opioids hyperalgesia assess monofilaments . However , Engelhardt et al [ 2008 ] show difference pain score postoperative opioid consumption . In addition , author observe high level proinflammatory cytokine , associate increase pain mouse receive chronic opioid ( morphine ) infusion [ Johnston et al. , 2004 ; Liang et al. , 2008 ] . Also , administration proinflammatory cytokine inhibitor reduce phosphorylation NMDA receptor [ Zhang et al. , 2008 ] . However , study examine relationship use remifentanil , frequently implicate opioid OIH [ Guignard et al. , 2000 ] , ketamine ( drug capable inhibit NMDA-receptors cytokine ) [ Dale et al. , 2012 ] , inflammatory response . The aim study determine addition ketamine reduce remifentanil-induced hyperalgesia , improve analgesic effect , inhibit IL-6 IL-8 ( inflammatory cytokine ) , stimulate IL-10 ( anti-inflammatory cytokine ) patient submit laparoscopic cholecystectomy , procedure usually neglect potential postoperative pain poorly investigate association OIH .</detailed_description>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>≥ 18 year old sexes ASA physical status I II undergo laparoscopic cholecystectomy chronic user analgesic use opioids within 12 h surgery history drug alcohol abuse psychiatric disorder contraindication selfadministration opioids ( ie , unable understand patientcontrolled analgesia [ PCA ] device ) contraindication use ketamine , psychiatric disorder , acute cardiovascular disorder , unstable hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Remifentanil</keyword>
	<keyword>Hyperalgesia</keyword>
	<keyword>Ketamine</keyword>
	<keyword>Von Frey 's filament</keyword>
	<keyword>Algometer</keyword>
	<keyword>Interleukines</keyword>
	<keyword>Opioid-induced hyperalgesia</keyword>
</DOC>